Share-based Payment Arrangement, Noncash Expense of ANAVEX LIFE SCIENCES CORP. from 30 Sep 2010 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount of noncash expense for share-based payment arrangement.
- Summary
-
ANAVEX LIFE SCIENCES CORP. quarterly and annual Share-based Payment Arrangement, Noncash Expense in USD history and change rate from 30 Sep 2010 to 31 Dec 2025.
- ANAVEX LIFE SCIENCES CORP. Share-based Payment Arrangement, Noncash Expense for the quarter ending 31 Dec 2025 was $1,107,000, a 46% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. Share-based Payment Arrangement, Noncash Expense for the twelve months ending 31 Dec 2025 was $10,601,000, a 15% increase year-over-year.
- ANAVEX LIFE SCIENCES CORP. annual Share-based Payment Arrangement, Noncash Expense for 2025 was $11,549,000, a 22% increase from 2024.
- ANAVEX LIFE SCIENCES CORP. annual Share-based Payment Arrangement, Noncash Expense for 2024 was $9,438,000, a 42% decline from 2023.
- ANAVEX LIFE SCIENCES CORP. annual Share-based Payment Arrangement, Noncash Expense for 2023 was $16,370,000, a 11% decline from 2022.
- Source SEC data
- View on sec.gov
Share-based Payment Arrangement, Noncash Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Noncash Expense, Quarterly (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Noncash Expense, Annual (USD)
Share-based Payment Arrangement, Noncash Expense, YoY Annual Change (%)
ANAVEX LIFE SCIENCES CORP. Quarterly Share-based Payment Arrangement, Noncash Expense (USD)
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $10,601,000 | $1,107,000 | -$948,000 | -46% | 01 Oct 2025 | 31 Dec 2025 | 10-Q | 09 Feb 2026 | 2026 | Q1 |
| Q3 2025 | $11,549,000 | $3,721,000 | +$1,709,000 | +85% | 01 Jul 2025 | 30 Sep 2025 | 10-K | 25 Nov 2025 | 2025 | FY |
| Q2 2025 | $9,840,000 | $4,324,000 | +$1,836,000 | +74% | 01 Apr 2025 | 30 Jun 2025 | 10-Q | 12 Aug 2025 | 2025 | Q3 |
| Q1 2025 | $8,004,000 | $1,449,000 | -$1,203,000 | -45% | 01 Jan 2025 | 31 Mar 2025 | 10-Q | 13 May 2025 | 2025 | Q2 |
| Q4 2024 | $9,207,000 | $2,055,000 | -$231,000 | -10% | 01 Oct 2024 | 31 Dec 2024 | 10-Q | 09 Feb 2026 | 2026 | Q1 |
| Q3 2024 | $9,438,000 | $2,012,000 | -$1,175,000 | -37% | 01 Jul 2024 | 30 Sep 2024 | 10-K | 25 Nov 2025 | 2025 | FY |
| Q2 2024 | $10,613,000 | $2,488,000 | -$1,378,000 | -36% | 01 Apr 2024 | 30 Jun 2024 | 10-Q | 12 Aug 2025 | 2025 | Q3 |
| Q1 2024 | $11,991,000 | $2,652,000 | -$1,318,000 | -33% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 13 May 2025 | 2025 | Q2 |
| Q4 2023 | $13,309,000 | $2,286,000 | -$3,061,000 | -57% | 01 Oct 2023 | 31 Dec 2023 | 10-Q | 12 Feb 2025 | 2025 | Q1 |
| Q3 2023 | $16,370,000 | $3,187,000 | -$2,855,159 | -47% | 01 Jul 2023 | 30 Sep 2023 | 10-K | 25 Nov 2025 | 2025 | FY |
| Q2 2023 | $19,225,159 | $3,866,000 | -$122,614 | -3.1% | 01 Apr 2023 | 30 Jun 2023 | 10-Q | 06 Aug 2024 | 2024 | Q3 |
| Q1 2023 | $19,347,773 | $3,970,000 | -$469,456 | -11% | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 09 May 2024 | 2024 | Q2 |
| Q4 2022 | $19,817,229 | $5,347,000 | +$1,438,229 | +37% | 01 Oct 2022 | 31 Dec 2022 | 10-Q | 07 Feb 2024 | 2024 | Q1 |
| Q3 2022 | $18,379,000 | $6,042,159 | +$2,890,554 | +92% | 01 Jul 2022 | 30 Sep 2022 | 10-K | 27 Nov 2023 | 2023 | FY |
| Q2 2022 | $15,488,446 | $3,988,614 | +$1,694,689 | +74% | 01 Apr 2022 | 30 Jun 2022 | 10-Q | 09 Aug 2022 | 2022 | Q3 |
| Q1 2022 | $13,793,757 | $4,439,456 | +$2,593,300 | +140% | 01 Jan 2022 | 31 Mar 2022 | 10-Q | 10 May 2022 | 2022 | Q2 |
| Q4 2021 | $11,200,457 | $3,908,771 | +$2,969,457 | +316% | 01 Oct 2021 | 31 Dec 2021 | 10-Q | 07 Feb 2023 | 2023 | Q1 |
| Q3 2021 | $8,231,000 | $3,151,605 | +$2,491,005 | +377% | 01 Jul 2021 | 30 Sep 2021 | 10-K | 27 Nov 2023 | 2023 | FY |
| Q2 2021 | $5,739,995 | $2,293,925 | +$1,042,796 | +83% | 01 Apr 2021 | 30 Jun 2021 | 10-Q | 09 Aug 2022 | 2022 | Q3 |
| Q1 2021 | $4,697,199 | $1,846,156 | +$145,403 | +8.5% | 01 Jan 2021 | 31 Mar 2021 | 10-Q | 10 May 2022 | 2022 | Q2 |
| Q4 2020 | $4,551,796 | $939,314 | -$325,110 | -26% | 01 Oct 2020 | 31 Dec 2020 | 10-Q | 09 Feb 2022 | 2022 | Q1 |
| Q3 2020 | $4,876,906 | $660,600 | 01 Jul 2020 | 30 Sep 2020 | 10-K | 28 Nov 2022 | 2022 | FY | ||
| Q2 2020 | $1,251,129 | 01 Apr 2020 | 30 Jun 2020 | 10-Q | 12 Aug 2021 | 2021 | Q3 | |||
| Q1 2020 | $1,700,753 | -$192,399 | -10% | 01 Jan 2020 | 31 Mar 2020 | 10-Q | 13 May 2021 | 2021 | Q2 | |
| Q4 2019 | $1,264,424 | -$802,563 | -39% | 01 Oct 2019 | 31 Dec 2019 | 10-Q | 16 Feb 2021 | 2021 | Q1 | |
| Q1 2019 | $1,893,152 | 01 Jan 2019 | 31 Mar 2019 | 10-Q | 07 May 2020 | 2020 | Q2 | |||
| Q4 2018 | $2,066,987 | +$945,002 | +84% | 01 Oct 2018 | 31 Dec 2018 | 10-Q | 06 Feb 2020 | 2020 | Q1 | |
| Q4 2017 | $1,121,985 | +$232,718 | +26% | 01 Oct 2017 | 31 Dec 2017 | 10-Q | 07 Feb 2019 | 2019 | Q1 | |
| Q4 2016 | $889,267 | +$63,247 | +7.7% | 01 Oct 2016 | 31 Dec 2016 | 10-Q | 07 Feb 2018 | 2017 | Q1 | |
| Q4 2015 | $826,020 | +$810,658 | +5277% | 01 Oct 2015 | 31 Dec 2015 | 10-Q | 07 Feb 2017 | 2017 | Q1 | |
| Q4 2014 | $15,362 | +$15,362 | 01 Oct 2014 | 31 Dec 2014 | 10-Q | 08 Feb 2016 | 2016 | Q1 | ||
| Q4 2013 | $0 | $0 | 01 Oct 2013 | 31 Dec 2013 | 10-Q | 17 Feb 2015 | 2015 | Q1 | ||
| Q4 2012 | $0 | -$123,264 | -100% | 01 Oct 2012 | 31 Dec 2012 | 10-Q | 14 Feb 2014 | 2014 | Q1 | |
| Q4 2011 | $123,264 | -$64,486 | -34% | 01 Oct 2011 | 31 Dec 2011 | 10-Q | 14 Feb 2013 | 2013 | Q1 | |
| Q4 2010 | $187,750 | 01 Oct 2010 | 31 Dec 2010 | 10-Q | 14 Feb 2012 | 2012 | Q1 |
ANAVEX LIFE SCIENCES CORP. Annual Share-based Payment Arrangement, Noncash Expense (USD)
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $11,549,000 | +$2,111,000 | +22% | 01 Oct 2024 | 30 Sep 2025 | 10-K | 25 Nov 2025 | 2025 | FY |
| 2024 | $9,438,000 | -$6,932,000 | -42% | 01 Oct 2023 | 30 Sep 2024 | 10-K | 25 Nov 2025 | 2025 | FY |
| 2023 | $16,370,000 | -$2,009,000 | -11% | 01 Oct 2022 | 30 Sep 2023 | 10-K | 25 Nov 2025 | 2025 | FY |
| 2022 | $18,379,000 | +$10,148,000 | +123% | 01 Oct 2021 | 30 Sep 2022 | 10-K | 27 Nov 2023 | 2023 | FY |
| 2021 | $8,231,000 | +$3,354,094 | +69% | 01 Oct 2020 | 30 Sep 2021 | 10-K | 27 Nov 2023 | 2023 | FY |
| 2020 | $4,876,906 | -$1,553,967 | -24% | 01 Oct 2019 | 30 Sep 2020 | 10-K | 28 Nov 2022 | 2022 | FY |
| 2019 | $6,430,873 | +$913,869 | +17% | 01 Oct 2018 | 30 Sep 2019 | 10-K | 28 Dec 2020 | 2020 | FY |
| 2018 | $5,517,004 | +$1,381,434 | +33% | 01 Oct 2017 | 30 Sep 2018 | 10-K | 16 Dec 2019 | 2019 | FY |
| 2017 | $4,135,570 | -$926,697 | -18% | 01 Oct 2016 | 30 Sep 2017 | 10-K | 25 Jan 2019 | 2018 | FY |
| 2016 | $5,062,267 | +$3,428,288 | +210% | 01 Oct 2015 | 30 Sep 2016 | 10-K | 25 Jan 2019 | 2018 | FY |
| 2015 | $1,633,979 | +$996,054 | +156% | 01 Oct 2014 | 30 Sep 2015 | 10-K | 11 Dec 2017 | 2017 | FY |
| 2014 | $637,925 | -$364,575 | -36% | 01 Oct 2013 | 30 Sep 2014 | 10-K | 14 Dec 2016 | 2016 | FY |
| 2013 | $1,002,500 | +$700,292 | +232% | 01 Oct 2012 | 30 Sep 2013 | 10-K | 29 Dec 2014 | 2014 | FY |
| 2012 | $302,208 | -$970,954 | -76% | 01 Oct 2011 | 30 Sep 2012 | 10-K | 30 Dec 2013 | 2013 | FY |
| 2011 | $1,273,162 | +$503,107 | +65% | 01 Oct 2010 | 30 Sep 2011 | 10-K | 31 Dec 2012 | 2012 | FY |
| 2010 | $770,055 | 01 Oct 2009 | 30 Sep 2010 | 10-K | 22 Dec 2011 | 2011 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.